Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;93(3):334-335.
doi: 10.1136/jnnp-2021-326779. Epub 2021 Jul 14.

Frequency of MOG-IgG in cerebrospinal fluid versus serum

Samuel Pace  1 , Michael Orrell  1 , Mark Woodhall  2   3 , Jacqueline Palace  3 , Maria Isabel Leite  3 , Sarosh R Irani  2   3 , Patrick Waters  2   3 , Adam E Handel  4   3
Affiliations

Frequency of MOG-IgG in cerebrospinal fluid versus serum

Samuel Pace et al. J Neurol Neurosurg Psychiatry. 2022 Mar.
No abstract available

Keywords: clinical neurology; neuroimmunology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: PW is a named inventor on patents for antibody assays and has received royalties. He has received honoraria from Biogen Idec, Mereo Biopharma, Retrogenix, UBC, Euroimmun AG and Alexion; travel grants from the Guthy-Jackson Charitable Foundation; and research funding from Euroimmun AG.

References

    1. Jurynczyk M, Messina S, Woodhall MR, et al. . Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 2017;140:3128–38. 10.1093/brain/awx276 - DOI - PubMed
    1. Mariotto S, Gajofatto A, Batzu L, et al. . Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases. Neurology 2019;93:10.1212/WNL.0000000000008479–72. 10.1212/WNL.0000000000008479 - DOI - PubMed
    1. Aoe S, Kume K, Takata T, et al. . Clinical significance of assaying anti-MOG antibody in cerebrospinal fluid in MOG-antibody-associated diseases: a case report. Mult Scler Relat Disord 2019;28:165–6. 10.1016/j.msard.2018.12.035 - DOI - PubMed
    1. Waters PJ, Komorowski L, Woodhall M, et al. . A multicenter comparison of MOG-IgG cell-based assays. Neurology 2019;92:10.1212/WNL.0000000000007096–55. 10.1212/WNL.0000000000007096 - DOI - PMC - PubMed
    1. Jarius S, Ruprecht K, Kleiter I, et al. . MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation 2016;13:279. 10.1186/s12974-016-0717-1 - DOI - PMC - PubMed

Publication types

Substances